Back
Santhera Pharmaceuticals Holding AG 10K Form
Sell
42
SPHDF
Santhera Pharmaceuticals Holding AG
Last Price:
9.42
Seasonality Move:
8.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SPHDF News And Ratings
See the #1 stock for the next 7 days that we like better than SPHDF
SPHDF Financial Statistics
Sales & Book Value
| Annual Sales: | $115.17M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 1.93 |
| Annual Sales: | $4.57 |
| Price / Book: | 2.13 |
Profitability
| EPS (TTM): | 6.51850 |
|---|---|
| Net Income (TTM): | $71.27M |
| Gross Margin: | $111.57M |
| Return on Equity: | 276.68% |
| Return on Assets: | 66.59% |
Santhera Pharmaceuticals Holding AG Earnings Forecast
Key Santhera Pharmaceuticals Holding AG Financial Ratios
- The Gross Profit Margin over the past 17 years for SPHDF is 96.87%.
- The Selling, General & Administrative Expenses for SPHDF have been equal to 29.94% of Gross Profit Margin.
- The Research & Development expenses have been 18.06% of Revenue.
- The Interest Expense is 38.91% of Operating Income.
- The Net Earning history of SPHDF is 52.97% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 10 years.
Santhera Pharmaceuticals Holding AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SPHDF |
| Website: | santhera.com |
Debt
| Debt-to-Equity Ratio: | 0.49 |
|---|---|
| Current Ratio: | 0.63 |
| Quick Ratio: | 0.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 1.69 |
|---|---|
| Forward P/E Ratio: | 0 |
SPHDF Technical Analysis vs Fundamental Analysis
Sell
42
Santhera Pharmaceuticals Holding AG (SPHDF)
is a Sell
Is Santhera Pharmaceuticals Holding AG a Buy or a Sell?
-
Santhera Pharmaceuticals Holding AG stock is rated a Sell
The current Santhera Pharmaceuticals Holding AG [SPHDF] share price is $9.42. The Score for SPHDF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.